Advertisement
Screener

ASTROTECH Corp (ASTC) Borrowing debt

ASTROTECH Corp (ASTC) Borrowing debt

  • Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2014-06-30..
  • Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2014-06-30..
  • Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2014-06-30..

Borrowing debt

Overview →

Financial period ending 2014-06-30; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
Total debt · latest quarter (USD)(m)Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2014-06-30.

Calculation unavailable: missing inputs remain (m).

Net cash · latest quarter(m)Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2014-06-30.

Calculation unavailable: missing inputs remain (m).

Debt / assets · latest quarter(m)Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2014-06-30.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Borrowing debt due within one year5.66M USDLong-term Debt, Current Maturities
Borrowing debt due after one year(m)Long-term Debt, Excluding Current Maturities
Commercial paper(m)
Cash and current securities(m)Cash and Cash Equivalents, at Carrying Value · Debt Securities, Available-for-sale, Current · Available-for-sale Securities, Current
Borrowing debt(m)Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities
Total assets40.78M USDAssets

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingTotal debtNet cash / debtBorrowing debt due within one year (USD)Borrowing debt due after one year (USD)Commercial paper (USD)Cash and current securities (USD)Total assets (USD)Debt / assets
2014-06-30(m)(m)$5.66M(m)(m)(m)$40.78M(m)
2014-03-31(m)(m)$5.75M(m)(m)(m)$42.86M(m)
2013-12-31(m)(m)$395.00K$5.46M(m)(m)$43.85M(m)
2013-09-30(m)(m)$391.00K$5.56M(m)(m)$47.94M(m)
2013-06-30(m)(m)$387.00K$5.66M(m)(m)$48.00M(m)
2013-03-31(m)(m)$383.00K$5.75M(m)(m)$46.48M(m)
2012-12-31(m)(m)$380.00K$5.85M(m)(m)$46.37M(m)
2012-09-30(m)(m)$375.00K$5.95M(m)(m)$47.72M(m)
2012-06-30(m)(m)$372.00K$6.04M(m)(m)$50.05M(m)
2012-03-31(m)(m)$368.00K$6.13M(m)(m)$56.31M(m)
2011-12-31(m)(m)$361.00K$6.23M(m)(m)$57.69M(m)
2011-09-30(m)(m)$361.00K$6.32M(m)(m)$57.65M(m)
2011-06-30(m)(m)$348.00K$6.42M(m)(m)$57.62M(m)

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.

Similar stocks

Stock NameCountryMarket CapPE Ratio
Bionano Genomics, Inc. (BNGO)United States$0.020B-0.42
HARVARD BIOSCIENCE INC (HBIO)United States$0.037B-2.70
Precipio, Inc. (PRPO)United States$0.043B-36.70
Seer, Inc. (SEER)United States$0.104B-1.34
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Quanterix Corp (QTRX)United States$0.150B-1.65
EyePoint, Inc. (EYPT)United States$0.314B-3.96
908 Devices Inc. (MASS)United States$0.476B-9.53
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15